Open AccessTransition period of estrogen-progestogen hormone therapy
Author(s) -
И. В. Кузнецова
Publication year - 2019
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2019-3-25(400)-6-10
Subject(s) - hormone , progestogen , medicine , estrogen , hormonal contraception , pregnancy , hormonal therapy , menstrual cycle , family planning , fertility , physiology , intensive care medicine , population , biology , research methodology , cancer , environmental health , prostate cancer , genetics
Combined hormonal contraception is an effective method of preventing pregnancy and at the same time has a number of therapeutic effects. The need for contraception persists until the final cessation of menstrual function, but at an older fertile age, the selection of a hormonal agent becomes a daunting task. Over the past years, a woman has accumulated factors that can complicate the use of hormonal drugs, and, on the other hand, new problems arise in the transitional period of life, which combined contraceptives can solve. An equally relevant topic is the question of stopping the use of combined hormonal contraceptives and initiating menopausal hormone therapy. All of the above aspects of the use of hormonal drugs require deep understanding for the adequate management of women entering the final phase of reproductive life.